Stay updated on Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial page.

Latest updates to the Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision: v3.5.0 was rolled out, replacing the previous v3.4.3 release. The update appears to be a routine site version upgrade with no visible changes to the study details or functionality on this page.SummaryDifference0.1%

- Check25 days agoChange DetectedVersion bumped from v3.4.2 to v3.4.3 on the site.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision: v3.4.2 replaces v3.4.1 in the page metadata. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page shows a minor revision update from v3.4.0 to v3.4.1; no changes to core study content or functionality are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check67 days agoChange DetectedGlossary is now shown; a new metadata entry 'Last Update Submitted that Met QC Criteria' has been added along with the site revision label 'Revision: v3.4.0' (while capitalization/phrasing of QC-related items was adjusted).SummaryDifference0.2%

- Check82 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing v3.3.3 (a minor internal update with no user-visible changes). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial page.